Potential for use of retinoic acid as an oral vaccine adjuvant

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1671, 2015, Pages

  Mwanza Lisulo, Mpala ^a   Kelly, Paul ^a,b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adjuvants; Retinoic acid; Vaccines; Vitamin A

Indexed keywords

CHOLERA; DIARRHEAL DISEASE; METABOLITE; MORTALITY; PATHOGEN; POLYSACCHARIDE; PRIMATE; TYPHOID; VACCINATION; VITAMIN;

ANIMALIA; PRIMATES; ROTAVIRUS;

IMMUNOLOGICAL ADJUVANT; RETINOIC ACID; VACCINE;

HUMAN; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; HUMANS; TRETINOIN; VACCINES;

EID: 84929245814     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0145     Document Type: Review

References (62)

1. Liu L et al. 2012 Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161. (doi:10.1016/S0140-6736(12)60560-1)
2. UNICEF/WHO 2009 Diarrhoea: why children are still dying and what can be done. Geneva, Switzerland: UNICEF/WHO.
3. Kotloff KL et al. 2013 Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382, 209–222. (doi:10.1016/S0140-6736(13)60844-2)
4. Norris SA, Wrottesley S, Mohamed RS, Micklesfield LK. 2014 Africa in transition: growth trends in children and implications for nutrition. Ann. Nutr. Metab. 64, 8–13. (doi:10.1159/000365122)
5. Neutra MR, Kozlowski PA. 2006 Mucosal vaccines: the promise and challenge. Nat. Rev. Immunol. 6, 148–158. (doi:10.1038/nri1777)
6. Lycke N. 2012 Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol. 12, 592–605. (doi:10.1038/nri3251)
7. Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, Tangermann RH, Armstrong GL. 2014 Possible eradication of wild poliovirus type 3—worldwide. 2012 MMWR Morb. Mortal. Wkly Rep. 63, 1031–1033.
8. Levine MM. 2010 Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BioMed. Cent. Biol. 8, 129.
9. Vesikari T et al. 2006 Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl. J. Med. 354, 23–33. (doi:10.1056/NEJMoa052664)
10. Mahdi SA et al. 2010 Effect of human rotavirus vaccine on severe diarrhea in African infants. New Engl. J. Med. 362, 289–298. (doi:10.1056/NEJMoa0904797)
11. de Palma O et al. 2010 Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 340, c2825. (doi:10.1136/bmj.c2825)
12. Zaman K et al. 2010 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebocontrolled trial. Lancet 376, 615–623. (doi:10.1016/S0140-6736(10)60755-6)
13. Hird TR, Grassly NC. 2012 Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 8, e1002599. (doi:10.1371/journal.ppat.1002599)
14. Parker EP, Kampmann B, Kang G, Grassly NC. 2014 Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and metaanalysis. J. Infect. Dis. 210, 853–864. (doi:10.1093/infdis/jiu182)
15. Qadri F, Bhuiyan T, Sack D, Svennerholm A. 2013 Immune responses and protection in children in developing countries induced by oral vaccines. Vaccine 31, 452–460. (doi:10.1016/j.vaccine.2012.11.012)
16. Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM. 2014 Helicobacter pylori infection affects immune responses following vaccination of typhoidnaive US adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J. Infect. Dis. 209, 1452–1458. (doi:10.1093/infdis/jit625)
17. Harrison EH. 2012 Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochim. Biophys. Acta 1821, 70–77. (doi:10.1016/j.bbalip.2011.06.002)
18. Thurnham DI. 2014 Interactions between nutrition and immune function: using inflammation biomarkers to interpret micronutrient status. Proc. Nutr. Soc. 73, 1–8. (doi:10.1017/S0029665113003662)
19. Ghana VAST Study Team. 1994 Vitamin A supplementation in Northern Ghana. Effects on clinic attendances, hospital admissions and child mortality. Lancet 344, 228–231.
20. Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA. 2011 Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and metaanalysis. BMJ 343, d5094. (doi:10.1136/bmj.d5094)
21. Awasthi S, Peto R, Read S, Clark S, Pande V, Bundy D. 2013 Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet 381, 1469–1477. (doi:10.1016/S0140-6736(12)62125-4)
22. Ross AC. 2007 Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo. Vitam. Horm. 75, 197–222. (doi:10.1016/S0083-6729(06)75008-7)
23. Villamor E, Fawzi WW. 2005 Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin. Microbiol. Rev. 18, 446–464. (doi:10.1128/CMR.18.3.446-464.2005)
24. D’Ambrosio DN, Clugston RD, Blaner WS. 2011 Vitamin A metabolism: an update. Nutrients 3, 63–103. (doi:10.3390/nu3010063)
25. Hollander D. 1980 Retinol lymphatic and portal transport: influence of pH, bile, and fatty acids. Am. J. Physiol. 239, GZlO-G214.
26. Crabb DW et al. 2001 Alcohol and retinoids. Alcohol. Clin. Exp. Res. 25, 207S–217S. (doi:10.1111/j.1530-0277.2001.tb02398.x)
27. Levin MS, Davis AE. 1997 Retinoic acid increases cRBP-II mRNA and retinol uptake in the human intestinal Caco-2 cell line. J. Nutr. 127, 13–17.
28. Zhang L, Xueping E, Luker KE, Shao J-S, Levin MS, Suh E, Li E. 2002 Analysis of human cRBP-II promoter during enterocyte differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G1079–G1087. (doi:10.1152/ajpgi.00041.2001)
29. Thatcher JE, Zelter A, Isoherranen N. 2010 The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acid. Biochem. Pharmacol. 80, 903–912. (doi:10.1016/j.bcp.2010.05.023)
30. Tang X-H, Gudas LJ. 2011 Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. Mech. Dis. 6, 345–364. (doi:10.1146/annurev-pathol-011110-130303)
31. Chambon P. 1996 A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940–954.
32. Rhinn M, Dollé P. 2012 Retinoic acid signaling during development. Development 139, 843–858. (doi:10.1242/dev.065938)
33. Ross AC, Chen Q, Ma Y. 2011 Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam. Horm. 86, 103–126. (doi:10.1016/B978-0-12-386960-9.00005-8)
34. DeCicco KL, Ross AC. 2000 All-trans retinoic acid and PIC cooperate to elevate anti-tetanus IgG and IgM responses in vitamin A-deficient Lewis rats and BALB/c mice. Proc. Nutr. Soc. 59, 519–529. (doi:10.1017/S0029665100000756)
35. Ma YF, Ross AC. 2005 The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic acid:polyribocytidylic acid. Proc. Natl Acad. Sci. USA 102, 13 556–13 561. (doi:10.1073/pnas.0506438102)
36. Semba RD, Muhilal M, Ward BJ, Griffin DE, Scott AL, Natadisastra G, West KP, Sommer A. 1993 Abnormal T cell subset proportions in vitamin A deficient children. Lancet 341, 5–8. (doi:10.1016/0140-6736(93)92478-C)
37. Wieringa FT, Dijkhuizen MA, West CE, van der Ven-Jongekrijg J, van der Meer JW, Muhilal M. 2004 Reduced production of immunoregulatory cytokines in vitamin A- and zinc-deficient Indonesian infants. Eur. J. Clin. Nutr. 58, 1498–1504. (doi:10.1038/sj.ejcn.1601998)
38. Savy M, Edmond K, Fine PE, Hall A, Hennig BJ, Moore SE, Mulholland K, Schaible U, Prentice AM. 2009 Landscape analysis of interactions between nutrition and vaccine responses in children. J. Nutr. 139, 2154S–2218S. (doi:10.3945/jn.109.105312)
39. Rahman MM, Alvarez JO, Mahalanabis D, Islam MA, Unicomb HD, Fuchs GJ. 1998 Effect of vitamin A administration on response to oral polio vaccination. Nutr. Res. 18, 1125–1133. (doi:10.1016/S0271-5317(98)00094-3)
40. Bahl R, Bhandari N, Kant S, Mølbak K, Østergaard E, Bhan MK. 2002 Effect of vitamin A administered at an expanded program on immunization contacts on antibody response to oral polio vaccine. Eur. J. Clin. Nutr. 56, 321–325. (doi:10.1038/sj.ejcn.1601325)
41. Lisulo MM, Kapulu MC, Banda R, Sinkala E, Kayamba V, Sianongo S, Kelly P. 2013 Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men. Clin. Exp. Immunol. 175, 468–475. (doi:10.1111/cei.12238)
42. Semba R, Muhilal M, Mohgaddam Nasrin NE, Munasir Z, Akib A, Permaesih D, Muherdiyantiningsih MS, Osterhaus Ab ADME. 1999 Integration of vitamin A supplementation with the expanded program on immunization does not affect seroconversion to oral poliovirus vaccine in infants. J. Nutr. 129, 2203–2205.
43. Surman S, Jones B, Rudraraju R, Sealy RE, Hurwitz JL. 2014 Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin Adeficient host. Clin. Vaccine Immunol. 21, 598–601. (doi:10.1128/CVI.00757-13)
44. Surman S, Jones B, Sealy RE, Rudraraju R, Hurwitz JL. 2014 Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice. Vaccine 32, 2521–2524. (doi:10.1016/j.vaccine.2014.03.025)
45. Chattha KS, Kandasamy S, Vlasova AN, Saif LJ. 2013 Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model. PLoS ONE 8, e82966. (doi:10.1371/journal.pone.0082966)
46. Kaufman DR, De Calisto J, Simmons NL, Cruz AN, Villablanca EJ, Mora JR, Barouch DH. 2011 Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity. J. Immunol. 187, 1877–1883. (doi:10.4049/jimmunol.1101248)
47. Adams J. 2010 The neurobehavioral teratology of retinoids: a 50-year history. Birth Defects Res. A 88, 895–905. (doi:10.1002/bdra.20721)
48. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. 2004 Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527–538. (doi:10.1016/j.immuni.2004.08.011)
49. Zeng R, Oderup C, Yuan R, Lee M, Habtezion A, Hadeiba H, Butcher EC. 2013 Retinoic acid regulates the development of a gut homing precursor for intestinal dendritic cells. Muc. Immunol. 6, 847–856. (doi:10.1038/mi.2012.123)
50. Sato T et al. 2013 Human CD1c+ myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D3. J. Immunol. 191, 3152–3160. (doi:10.4049/jimmunol.1203517)
51. Iwata M, Mukai M, Nakai Y, Iseki R. 1992 Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J. Immunol. 149, 3302–3308.
52. Yang Y, Vacchio MS, Ashwell JD. 1993 9-cis-Retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl Acad. Sci. USA 90, 6170–6174. (doi:10.1073/pnas.90.13.6170)
53. Iwata M. 2009 Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin. Immunol. 21, 8–13. (doi:10.1016/j.smim.2008.09.002)
54. Hammerschmidt S, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, Pabst O, Forster R. 2011 Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunisation of mice. J. Clin. Invest. 121, 3051–3061. (doi:10.1172/JCI44262)
55. Tan X, Sande J, Pufnock JS, Blattman JN, Greenberg PD. 2011 Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J. Virol. 85, 8316–8327. (doi:10.1128/JVI.00781-11)
56. Bernardo D et al. 2013 Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: stable restoration of gut specificity with retinoic acid. Clin. Exp. Immunol. 174, 109–119. (doi:10.1111/cei.12118)
57. Saurer L, McCullough KC, Summerfield A. 2007 In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J. Immunol. 179, 3504–3514. (doi:10.4049/jimmunol.179.6.3504)
58. Evans T, Reeves R. 2013 All-trans-retinoic acid imprints expression of the gut-homing marker a4b7 while suppressing lymph node-homing of dendritic cells. Clin. Vacc. Immunol. 20, 1642–1646. (doi:10.1128/CVI.00419-13)
59. Mora JR et al. 2006 Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314, 1157–1160. (doi:10.1126/science.1132742)
60. Chen Q, Mosovsky KL, Ross AC. 2013 Retinoic acid and a-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation. Immunobiology 218, 1477–1487. (doi:10.1016/j.imbio.2013.05.003)
61. Brandtzaeg P. 2013 Secretory IgA: designed for antimicrobial defense. Front. Immunol. 4, 222. (doi:10.3389/fimmu.2013.00222)
62. Takenouchi N, Asano M, Chihaya H, Chung-Hsuing WU, Ishikasa K, Moro I. 2004 Retinoic acid enhances the gene expression of human polymeric immunoglobulin receptor (pIgR) by TNF-a. Clin. Exp. Immunol. 135, 448–454. (doi:10.1111/j.1365-2249.2004.02398.x)